University of the Witwatersrand
Also known as: Chris Hani Baragwanath Hospital | Clinical HIV Research Unit, University of the Witwatersrand | Ezintsha, a subdivision of Wits Reproductive Health and HIV Institute (Wits RHI) | Ezintsha, Faculty of Health Sciences University of the Witwatersrand | Harriet Shezi Children's Clinic, Chris Hani Baragwanth Hospital, WHI, University of the Witwatersrand | Jeffrey Kotzen | Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital | Perinatal HIV Research Unit, Chris Hani Baragwanath Hospital, University of the Witwatersrand | Perinatal HIV Research Unit of the University of the Witswatersrand | Perinatal HIV Research Unit of the University of the Witwatersrand | Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Hospital | Perinatal HIV Research Unit, University of Witwatersrand | RHRU National Office, University of Witwatersand, Johannesburg | Senior Radiation Oncologist | Shabir Madhi | Student - PhD Candidate | Univeristy of the Witwatersrand | University of the Witwatersrand. Themba Lethu Clinic. | University of the Witwatersrand, Thembaletu Clinic, Helen Joseph Hospital | University of Witwatersrand | University of Witwatersrand, South Africa | University of Witwatetersrand & Charlotte Maxek Johannestburg Academic Hospital | University or Witswatersrand | VPD- RMPRU | Willem Daniel Francois Venter | Wits Reproductive Health & HIV Institute, University of the Witswatersrand
Highest phase reached
Phase 4
First clinical trial
Feb 1, 2004Last known activity
Aug 31, 2025
Timeline
1890s
- Jun 1, 1896
University of the Witwatersrand— Founded
Drugs by trial phase (88 distinct, 68 trials)
Phase 4 (27 own, 0 via acquisition)
Phase 3 (33 own, 0 via acquisition)
Phase 2 (16 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Breast Neoplasms
- Chickenpox
- Communicable Diseases
- Coronavirus Infections
- Extensively Drug-Resistant Tuberculosis
- Fever
- Hepatitis
- Hepatitis A
- Herpes Simplex
- Herpes Zoster
- HIV Infections
- Hypercholesterolemia
- Hyperlipoproteinemia Type II
- Immunologic Deficiency Syndromes
- Infections
- Influenza, Human
- Latent Tuberculosis
- Measles
- Meningitis
- Papillomavirus Infections
- Pneumonia
- Pneumonia, Pneumocystis
- Postoperative Pain
- Severe Acute Respiratory Syndrome
- Squamous Intraepithelial Lesions of the Cervix
- Surgical Wound Infection
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- Tuberculosis, Pulmonary
- Uterine Cervical Dysplasia
- Uterine Cervical Neoplasms
- Varicose Ulcer
Recent trials (50)
- NCT07118059CollaboratorPhase 2Aug 31, 2025
- NCT06436274CollaboratorPhase 4Sep 30, 2024
- NCT06446752CollaboratorPhase 3Aug 31, 2024
- NCT06485154Sponsor investigatorPhase 4Jun 1, 2024
- NCT06485154Lead sponsorPhase 4Jun 1, 2024
- NCT05924438Lead sponsorPhase 3Nov 8, 2023
- NCT05924438Sponsor investigatorPhase 3Nov 8, 2023
- NCT06138600Reponsible party - principal investigatorPhase 3Nov 1, 2023
- NCT06138600Sponsor investigatorPhase 3Nov 1, 2023
- NCT06138600Lead sponsorPhase 3Nov 1, 2023
- NCT07006246Lead sponsorPhase 4May 19, 2023
- NCT07006246Sponsor investigatorPhase 4May 19, 2023
- NCT05413122CollaboratorPhase 4Feb 1, 2023
- NCT05459532Study directorPhase 3Aug 12, 2022
- NCT05459532Reponsible party - principal investigatorPhase 3Aug 12, 2022
Details
- Founded
- Johannesburg, ZA Jun 1, 1896
- Last known activity
- Aug 31, 2025